Neuropsychiatric manifestations of prostate cancer and its treatment: Biological mechanisms and psycho-oncology perspectives

Prostate cancer (PCa) is the most frequently diagnosed malignancy in men and a leading cause of cancer-related mortality worldwide. Beyond its oncological burden, PCa is increasingly recognized as a condition with profound psychiatric and neurocognitive implications. Depression, anxiety, sleep disturbance and cognitive decline are highly prevalent among patients, particularly those undergoing androgen deprivation therapy or chemotherapy. The most consistent clinical evidence suggests associations between androgen deprivation therapy and mood-related morbidity, whereas findings for cognition and proposed mechanisms such as inflammation, oxidative stress, hypothalamic-pituitary-adrenal axis dysregulation and altered neural signaling remain heterogeneous and are not uniformly supported by PCa-specific prospective studies. Addressing these dimensions requires a holistic, multidisciplinary model of care in which mental health screening and psychiatric support are integrated into oncology practice. PCa thus serves as a paradigm for understanding the bidirectional relationship between chronic disease, treatment-induced biological stress and psychiatric health. This narrative review links evidence on treatment-related neuropsychiatric outcomes, proposed biological mechanisms, neuroimaging findings, societal aspects of neuropsychiatric morbidity in PCa, while also highlighting important areas for integrated care and future research. Sources such as PubMed/MEDLINE, Scopus, Web of Science, PsycINFO, Google Scholar and reference-list screening were used to identify English-language peer-reviewed literature published from January 2000 to November 2025.

Authors

Publication Details

Journal
World Journal of Psychiatry
Published
2026-11-19
DOI
https://doi.org/10.5498/wjp.125256
Primary Topic
Cancer-related cognitive impairment studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Neuropsychiatric manifestations of prostate cancer and its treatment: Biological mechanisms and psycho-oncology perspectives

Shivani Nandkishor Bhave, Akhilesh Prajapati, Yash Darji
World Journal of Psychiatry
Cancer-related cognitive impairment studies
article

Neuropsychiatric manifestations of prostate cancer and its treatment: Biological mechanisms and psycho-oncology perspectives

Shivani Nandkishor Bhave, Akhilesh Prajapati, Yash Darji
article en

Abstract

Prostate cancer (PCa) is the most frequently diagnosed malignancy in men and a leading cause of cancer-related mortality worldwide. Beyond its oncological burden, PCa is increasingly recognized as a condition with profound psychiatric and neurocognitive implications. Depression, anxiety, sleep disturbance and cognitive decline are highly prevalent among patients, particularly those undergoing androgen deprivation therapy or chemotherapy. The most consistent clinical evidence suggests associations between androgen deprivation therapy and mood-related morbidity, whereas findings for cognition and proposed mechanisms such as inflammation, oxidative stress, hypothalamic-pituitary-adrenal axis dysregulation and altered neural signaling remain heterogeneous and are not uniformly supported by PCa-specific prospective studies. Addressing these dimensions requires a holistic, multidisciplinary model of care in which mental health screening and psychiatric support are integrated into oncology practice. PCa thus serves as a paradigm for understanding the bidirectional relationship between chronic disease, treatment-induced biological stress and psychiatric health. This narrative review links evidence on treatment-related neuropsychiatric outcomes, proposed biological mechanisms, neuroimaging findings, societal aspects of neuropsychiatric morbidity in PCa, while also highlighting important areas for integrated care and future research. Sources such as PubMed/MEDLINE, Scopus, Web of Science, PsycINFO, Google Scholar and reference-list screening were used to identify English-language peer-reviewed literature published from January 2000 to November 2025.

World Journal of PsychiatryVol. 16(11)
Good health and well-being
Cancer-related cognitive impairment studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon